Lenz Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Lenz Therapeutics Inc 's inventory turnover ratio sequentially decreased to 0.62 in the second quarter 2026, unsurprisingly, as the Lenz Therapeutics Inc markets continue to deteriorate, and LENZ's faces growing challenges to bring down its inventories. Lenz Therapeutics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 589 days, from 451 days, in the Mar 31 2026 quarter.

Within Healthcare sector 344 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

LENZ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lenz Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LENZ Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-	-	-	-	-
Y / Y Cost of Sales Growth	-	-	-	-	-
Inventory Turnover Ratio (TTM)	0.62	0.81	0.43	-	-
LENZ's Total Ranking	#	#	#	#	#
Average inventory processing period	592	451	848	-	-
Seq. Inventory Growth	17.81 %	19.14 %	209.38 %	-	-
Seq. Cost of Sales Growth	-73.98 %	157.42 %	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 26
Healthcare Sector	# 345
Overall Market	#

Inventory Turnover Ratio Statistics
High	Average	Low
0.62	0.62	0.62
(Jun 30 2026)

LENZ Company Profile >> Back to LENZ Efficiency Comparisons >> Compare LENZ Inventory Turnover Ratio to its Competitors

Financial Statements
Lenz Therapeutics Inc 's Inventories	$ 4 Millions	Visit LENZ's Balance sheet
Lenz Therapeutics Inc 's Cost of Revenues TTM	$ 2 Millions	Visit LENZ's Income Statement
What are LENZ's Sales?		Visit LENZ's Sales by Segment

Other Inventory Turnover Ratios
Lenz Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LENZ's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LENZ's Competitors
Inventory Turnover Ratio for LENZ's Suppliers
Inventory Turnover Ratio for LENZ's Customers

You may also want to know
LENZ's Sales Growth Rates	LENZ's Pe Price to earnings ratio	LENZ's Receivables Turnover Ratio	LENZ's Stock Quote
LENZ's Net Income Growth Rates	LENZ's Ps Price to Sales ratio	LENZ's Sales per Employee	LENZ's Asset Turnover Ratio
LENZ's Net Margin	LENZ's Pb Price to Book ratio	LENZ's Financial Strength Ratios	LENZ's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Delcath Systems Inc	1.16	$ 12.355 Millions	$ 11 Millions
Bridgebio Pharma Inc	1.16	$ 39.655 Millions	$ 34 Millions
Neuropace Inc	1.14	$ 19.920 Millions	$ 17 Millions
Amarin Corp Plcuk	1.13	$ 108.346 Millions	$ 96 Millions
Treace Medical Concepts Inc	1.10	$ 42.186 Millions	$ 38 Millions
Corcept Therapeutics Inc	1.10	$ 14.085 Millions	$ 13 Millions
Zoetis Inc	1.08	$ 2,709.000 Millions	$ 2,505 Millions
Acadia Pharmaceuticals Inc	1.07	$ 100.979 Millions	$ 94 Millions
Bio Green Med Solution Inc	1.07	$ 1.244 Millions	$ 1 Millions
Hyperfine Inc	1.06	$ 6.924 Millions	$ 7 Millions
Pacira Biosciences inc	1.04	$ 155.154 Millions	$ 149 Millions
Humacyte Inc	1.03	$ 12.611 Millions	$ 12 Millions
Vertex Pharmaceuticals Inc	1.03	$ 1,762.800 Millions	$ 1,711 Millions
Tg Therapeutics Inc	1.03	$ 140.939 Millions	$ 137 Millions
Emergent Biosolutions Inc	1.02	$ 339.900 Millions	$ 333 Millions
Renovorx Inc	1.01	$ 0.308 Millions	$ 0 Millions
Alkermes Plc	1.01	$ 257.490 Millions	$ 256 Millions
Rhythm Pharmaceuticals Inc	0.99	$ 26.389 Millions	$ 27 Millions
Seer Inc	0.96	$ 7.596 Millions	$ 8 Millions
Protalix Biotherapeutics inc	0.91	$ 24.832 Millions	$ 27 Millions
Igc Pharma Inc	0.90	$ 0.745 Millions	$ 1 Millions
Neurocrine Biosciences Inc	0.89	$ 68.600 Millions	$ 77 Millions
Maxcyte inc	0.84	$ 6.450 Millions	$ 8 Millions
Establishment Labs Holdings Inc	0.83	$ 71.831 Millions	$ 86 Millions
Adma Biologics Inc	0.83	$ 179.465 Millions	$ 216 Millions
Tonix Pharmaceuticals Holding Corp	0.83	$ 4.706 Millions	$ 6 Millions
Petvivo Holdings Inc	0.83	$ 0.390 Millions	$ 0 Millions
Profound Medical Corp	0.81	$ 5.385 Millions	$ 7 Millions
Beone Medicines Ltd	0.79	$ 506.000 Millions	$ 639 Millions
Blue Water Vaccines Inc	0.78	$ 0.127 Millions	$ 0 Millions

Date modified: 2026-09-04T10:25:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.